Will AI-based tools embedded into risk based-monitoring prompt an Agile project management moment for clinical research? Sidharth Ananthanarayan explains why AI-based tools are not the answer but part of it.
- Why Clinical Trial Sites Are Drowning In Tech Chaos
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Executing Concurrent Decentralized RCTs And RWE At Scale
See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.
-
Why The Everest Group Named Medable A Leader In eCOA
Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.
-
How Site And Patient Research Optimizes Clinical Trials
Signant’s patient and site research enhances digital health technology in clinical trials by optimizing usability and design. These insights drive improvements in product features, study designs, and training materials.
-
Building A Scalable Oncology Engine In A Dynamic Market
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.
-
Bring Your Own Device (BYOD) Clinical Trials
Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.
-
Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.
-
From Imaging To Analysis: 5 Steps For Success With TrialKit PACS
Obtain a fully integrated platform that seamlessly connects imaging data with EDC systems, resulting in streamlined data acquisition, real-time collaboration, and advanced analysis within a unified system.
-
Addressing The Challenges Of eCOA Licensing
How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?
-
Demystifying AI: The Fundamentals And Applications In Drug Development
Explore the history of AI, gain clarity on key concepts, address common questions, and discover its transformative role in drug development, with insights into its current and future impact on the industry.
-
Safety Monitoring: What Does ePRO Have To Do With It?
In the available blog post, learn about the importance of safety monitoring in clinical trials.
RECENT NEWSLETTERS
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works